Genetic alterations, including microsatellite instability (MSI) and loss of heterozygosity (LOH), have been described in both malignant and benign diseases. Previous studies have successfully detected such alterations in sputum samples of patients with bronchial asthma (BA). The aim of this study was to assess the presence of MSI and/or LOH in nasal cytology samples of patients with allergic rhinitis (AR).
Methods
Nasal brush samples and peripheral blood from 20 patients with AR were analyzed. DNA was extracted and analyzed for MSI and LOH using the following microsatellite markers: D16S289, D4S2394, D4S1651, DXS8039, D3S3606, and D2S2113, harboring potential susceptibility genes for AR and atopy. Microsatellite analysis was performed also in eight control subjects.
Results
No MSI and/or LOH were noted in either the AR or the control group.
Conclusion
Although MSI and LOH are detectable phenomena in sputum samples of patients with BA, this seems not to be the case for nasal cytology samples of patients with AR. Additional studies are needed, using a larger number of polymorphic markers, to assess if such a difference exists among two diseases otherwise very closely related.
BousquetJ., Van CauwenbergeP., and KhaltaevN.Allergic rhinitis and its impact on asthma (ARIA).J Allergy Clin Immunol108: 5174–5334, 2001.
2.
NathanR.A., MeltzerE.O., SelnerJ.C., and StormsW.Prevelence of allergic rhinitis in the United States.J Allergy Clin Immunol99(suppl): S808–S814, 1997.
3.
StrachanD., SibbaldB., WeilandS.Worldwide variations in prevelance of symptoms of allergic rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC).Pediatr Allergy Immunol8: 161–176, 1997.
4.
BousquetJ., BullingerM., FayolC.Assessment of quality of life in patients with perennial rhinitis with the French version of the SF-36 Health Status Questionnaire.J Allergy Clin Immunol94: 182–188, 1994.
5.
HaagerupA., BjerkeT., SchoitzP.O.Allergic rhinitis—A total genome scan for susceptibility genes suggests a locus on chromosome 4q24–q27.Eur J Hum Genet9: 945–952, 2001.
6.
KurzT., AltmuellerJ., StrauchK.A genome-wide screen on the genetics of atopy in a multiethnic European population reveals a major atopy locus on chromosome 3q21.3.Allergy60: 192–199, 2005.
7.
BensonM., SvenssonP.A., AdnerM.DNA microarray analysis of chromosomal susceptibility regions to identify candidate genes for allergic disease: A pilot study.Acta Otolaryngol124: 813–819, 2004.
8.
GelfandA.W.Inflammatory mediators in allergic rhinitis.J Allergy Clin Immunol114: S135–S137, 2004.
9.
CruzA.A.The “united airways” require an holistic approach to management.Allergy60: 871–874, 2005.
10.
BraunstahlG.J., FokkensW.J., OverbeekS.E.Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: A comparison between upper and lower airways.Clin Exp Allergy33: 579–587, 2003.
11.
BousquetJ., JacquotW., VignolaA.M.Allergic rhinitis: A disease remodeling the airways?J Allergy Clin Immunol113: 43–49, 2004.
12.
SamaraK., ZervouM., SiafakasN.M., and TzortzakiE.G.Microsatellite DNA instability in benign lung diseases.Respir Med100: 202–211, 2006.
13.
LoebL.A.Microsatellite instability marker of a mutator phenotype in cancer.Cancer Res54: 5059–5063, 1994.
14.
FieldJ.K., KriarisH., HowardP.Microsatellite instability in squamous cell carcinoma of the head and neck.Br J Cancer75: 1065–1069, 1995.
15.
LoebL.A., and ChristianF.C.Multiple mutation in human cancer.Mutat Res350: 279–286, 1996.
16.
ParaskakisE., SourvinosG., PassamF.Microsatellite DNA instability and loss of heterozygosity in bronchial asthma.Eur Respir J22: 951–955, 2003.
17.
SpandidosD.A., ErgazakiM., HatzistamouJ.Microsatellite instability in patients with chronic obstructive pulmonary disease.Oncol Rep3: 489–491, 1996.
18.
SiafakasN.M., TzortzakiE.G., SourvinosG.Microsatellite DNA instability in COPD.Chest116: 47–51, 1999.
19.
ZervouM., TzortzakiE.G., MakrisD.Differences in microsatellite DNA level between asthma and COPD.Eur Respir J28(3): 472–478, 2006.
20.
DykewiczM.S., FinemanS., and SkonerD.P.Joint Task Force summary statements on diagnosis and management of rhinitis.Ann Allergy Asthma Immunol81: 474–477, 1998.
21.
PipkornU., KarlssonG., and EnerbackL.A brush method to harvest cells from the nasal mucosa for microscopic and biochemical analysis.J Immunol Methods112: 37–42, 1988.
22.
HowarthP.H., PerssonC.G.A., MeltzerE.O.Objective monitoring of nasal airway inflammation in rhinitis.J Allergy Clin Immunol115: S414–S441, 2005.
23.
ThomasN.S., WilkinsonJ., and HolgateS.T.The candidate region approach to the genetics of asthma and allergy.Am J Respir Crit Care Med15(suppl 4): 144–151, 1997.
24.
HaagerupA., BjerkeT., SchiotzP.O.Asthma and atopy—A total genome scan for susceptibility genes.Allergy57: 680–686, 2002.
25.
HaagerupA., BorglumA.D., BinderupA.G., and KruseT.A.Fine-scale mapping of type I allergy candidate loci suggests central susceptibility genes on chromosomes 3q, 4q and Xp.Allergy59: 88–94, 2004.
26.
JaworskiA., RoscheW.A., GellibolianR.Mismatch repair in Escherichia coli enhances instability of (CTG)n triplet repeats from human hereditary diseases.Proc Natl Acad Sci U S A92: 11019–11023, 1995.
27.
EpplenC., MeimerG., SiedlaczckI.On the essence of “meaningless” simple repetitive DNA in eukaryote genomes. DNA fingerprinting: State of the science.EXS67: 29–45, 1993.
28.
MetzgarD., BytofJ., and WillsC.Selection against frame shift mutations limits microsatellite expansion in coding DNA.Genome Res10: 72–80, 2000.
29.
LundbackB.Epidemiology o rhinitis and asthma.Clin Exp Allergy2: 3–10, 1998.
30.
LeynaertB., BousquetJ., NeukirchC.Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: Results from the European Community Respiratory Health Survey.J Allergy Clin Immunol104: 301–304, 1999.
31.
CalS., ObayaA.J., LlamazaresM.Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains.Gene283: 49–62, 2002.
32.
HorwitzM., BensonK.F., LiF.Q.Genetic heterogeneity in familial acute myelogenous leukemia: Evidence for a second locus at chromosome 16q21.23.2.Am J Hum Genet61: 873–881, 1997.
33.
Dorion-BonnetM., MautalenS., HosteinI., and LongyM.Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers.Genes Chromosomes Cancer14: 171–181, 1995.
34.
Brasch-AndersenC., HaagerupA., BorglumA.D.Highly significant linkage to chromosome 3q13.31 for rhinitis and related allergic diseases.J Med Genet43: e10, 2006.
